Abstract:Cardiac fibrosis is a major and complex pathophysiological process that ultimately culminates in cardiac dysfunction and heart failure. This phenomenon includes not only the replacement of the damaged tissue by a fibrotic scar produced by activated fibroblasts/myofibroblasts but also a spatiotemporal alteration of the structural, biochemical, and biomechanical parameters in the ventricular wall, eliciting a reactive remodeling process. Though mechanical stress, post-infarct homeostatic imbalances, and neurohormonal activation are classically attributed to cardiac fibrosis, emerging evidence that supports the roles of immune system modulation, inflammation, and metabolic dysregulation in the initiation and progression of cardiac fibrogenesis has been reported. Adaptive changes, immune cell phenoconversions, and metabolic shifts in the cardiac nonmyocyte population provide initial protection, but persistent altered metabolic demand eventually contributes to adverse remodeling of the heart. Altered energy metabolism, mitochondrial dysfunction, various immune cells, immune mediators, and cross-talks between the immune cells and cardiomyocytes play crucial roles in orchestrating the transdifferentiation of fibroblasts and ensuing fibrotic remodeling of the heart. Manipulation of the metabolic plasticity, fibroblast–myofibroblast transition, and modulation of the immune response may hold promise for favorably modulating the fibrotic response following different cardiovascular pathological processes. Although the immunologic and metabolic perspectives of fibrosis in the heart are being reported in the literature, they lack a comprehensive sketch bridging these two arenas and illustrating the synchrony between them. This review aims to provide a comprehensive overview of the intricate relationship between different cardiac immune cells and metabolic pathways as well as summarizes the current understanding of the involvement of immune–metabolic pathways in cardiac fibrosis and attempts to identify some of the previously unaddressed questions that require further investigation. Moreover, the potential therapeutic strategies and emerging pharmacological interventions, including immune and metabolic modulators, that show promise in preventing or attenuating cardiac fibrosis and restoring cardiac function will be discussed.

View from the heart: cardiac fibroblasts in development, scarring and regeneration

Role of Cardiac Fibroblasts in Cardiac Injury and Repair

Direct Reprogramming of Cardiac Fibroblasts to Repair the Injured Heart

Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction

Characterization of cardiac fibroblast-extracellular matrix crosstalk across developmental ages provides insight into age-related changes in cardiac repair

Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities

Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies

Complex Relationship Between Cardiac Fibroblasts and Cardiomyocytes in Health and Disease

Cardiac fibrosis.

Myofibroblasts and Fibrosis

Origin and Function of Activated Fibroblast States During Zebrafish Heart Regeneration.

Novel Techniques Targeting Fibroblasts after Ischemic Heart Injury

Cardiac Fibrosis: Key Role of Integrins in Cardiac Homeostasis and Remodeling

The adaptive immune response to cardiac injury—the true roadblock to effective regenerative therapies?

Spatio-temporal dynamics of the fibrotic niche in cardiac repair

Cardiac fibroblasts and mechanosensation in heart development, health and disease

Role of Cardiac Macrophages on Cardiac Inflammation, Fibrosis and Tissue Repair

The Pathogenesis of Cardiac Fibrosis: A Review of Recent Progress

Cardiac fibrogenesis: an immuno-metabolic perspective

Cardiac Fibroblastic Niches in Homeostasis and Inflammation

Single–cell transcriptional and epigenetic mapping reveals cellular and molecular mechanisms driving non-ischemic cardiac fibrosis